New artificial pancreas project aims to enhance diabetes treatment

A collaborative research project has been launched to lead the development of an innovative new type of artificial pancreas.

The partnership between CEA-Leti and Diabeloop will develop a device that automatically delivers the appropriate dose of insulin to patients with type 1 diabetes, building on earlier research showing the promise of a closed-loop system for treating the condition.

It will consist of a sensor to measure glucose levels, a pump that delivers insulin and a smartphone with an embedded algorithm and patient interface that links the sensor and the pump.

The device also includes telemedicine capabilities, facilitating remote monitoring of patients and making it easier for healthcare providers and dedicated nurses to intervene in medical emergencies.

Specific efforts will be made to refine the system's regulation algorithm to take into account the individual's carbohydrate intake, glycaemia, physical activity and emotional history.

Pierre Jallon, Leti's research and development manager for digital health and wellness systems, said: "Designed for maximum user convenience and optimal integration with healthcare providers, Diabeloop is a smart system that will provide a very precise dosage for diabetics."